Global ACD (Acid citrate dextrose) tubes market is expected to witness lucrative growth over the forecast period owing to the increasing demand of blood and blood components storage in hospitals, blood banks and clinics to prevent contamination of blood components by microscopic organisms like bacteria, viruses, and other disease-causing agents. The complications of contaminated blood transfusion can result in mild allergic reactions such as skin rash, swelling of the hands, feet, and legs along with high temperature. Hepatitis is the most common disease transmitted by blood transfusions. Increasing prevalence of such infections is expected to fuel the growth of acid citrate dextrose tubes industry over the forecast period.
Most of the diagnostic assessments are performed on serum, anti-coagulated plasma, or whole blood. The findings of the diagnostic labs are based on blood specimens submitted and if the storage is not proper, it can lead to wrong diagnosis for the patient. According to the National Health Service (NHS), the number of people aged 65 years and above is expected to rise by 65% in the next 25 years. As per the World Health Organization (WHO), it has been estimated that the global elderly population is expected to reach around 2 billion by 2050. Increase in the geriatric population is contributing towards increasing prevalence of arthritis, cardiovascular diseases, and cancer. Increase in these diseases need surgical interventions. In any surgical procedure performed on the patient, there is blood loss from the body and blood transfusion plays an important role to maintain the required blood volume. Apart from rise in surgical procedures, blood transfusion is also necessary in accident cases and during dialysis conditions. New advancements in the development of ACD tubes are driving health care centers, diagnostic centers, and clinics to adopt the use of advanced ACD tubes for long term and short term preservation of blood.
On the basis of application, the ACD tubes market is segmented into cancer, arthritis, and cardiovascular diseases. ACD is a combination of citric acid, dextrose, and sodium citrate in water, which is used as an anticoagulant for preserving blood samples. These are special tubes used for preserving the blood specimens. On the basis of end-use, the Acid citrate dextrose tubes market is segmented into hospitals, diagnostics centers, and health care clinics across the globe. Different specifications of Acid citrate dextrose tubes are available and these used for blood specimen storage. The stored specimens are used for immediate investigation or for future investigations. Increasing health care hazards associated with transfusion of contaminated blood are a matter of high concern for all health care professionals, patients, and other stakeholders. Hence proper hygiene and standards are required in the preservation of blood.
Geographically, North America and Europe contribute to the maximum share for ACD tubes owing to increasing awareness for safe blood storage, blood transfusion, rise in the geriatric population, and better health care standards. These regions have better reach to technological advancements and can invest resources in procuring the best health care solutions. Over the forecast period, Asia Pacific region is expected to have the fastest growth for these devices due increase in public and private health care expenditure to meet global standards coupled with increase in awareness about hygiene factors in blood transfusion and blood preservation is a major driver in Asia-pacific region. Technological advancements and increase in health care spending will reduce the affordability constraint and further accelerate the adoption of ACD tubes across health care facilities, diagnostic centers and clinics in Latin America, the Middle East, and Africa.
The major players in the ACD tubes market are Fisher Scientific UK Ltd, Becton Dickinson and Company, and Cryoquip LLC. With the growth of the market, more players are expected to enter the market and increase competition and drive the market growth for ACD tubes
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.